DEVELOPMENT OF SELECTIVE DOPAMINE RECEPTOR AGONISTS AS NOVEL CARDIOVASCULAR DRUGS

被引：18

作者：

HAHN, RA

机构：

来源：

DRUG DEVELOPMENT RESEARCH | 1984年 / 4卷 / 03期

关键词：

D O I：

10.1002/ddr.430040306

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：285 / 300

页数：16

共 76 条

[1] RENAL VASODILATORS AND HYPERTENSION [J].

ACKERMAN, DM ;

WEINSTOCK, J ;

WIEBELHAUS, VD ;

BERKOWITZ, B .

DRUG DEVELOPMENT RESEARCH, 1982, 2 (03) :283-297

[2]

ACKERMAN DM, 1983, FED PROC, V42, P748

[3]

ACKERMAN DM, 1982, FED PROC, V41, P1546

[4]

ACKERMAN DM, 1981, FED PROC, V40, P585

[5]

ACKERMAN DM, 1980, FED PROC, V39, P949

[6] LY-141865 STIMULATES HISTAMINE-2 (H-2) RECEPTORS AND DOPAMINE-2 (DA2) RECEPTORS IN THE ANESTHETIZED DOG [J].

ARMSTRONG, JM ;

DUVAL, N ;

LANGER, SZ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (01) :165-166

[7] BICYCLIC AND TRICYCLIC ERGOLINE PARTIAL STRUCTURES - RIGID 3-(2-AMINOETHYL)PYRROLES AND 3-(2-AMINOETHYL)PYRAZOLE AND 4-(2-AMINOETHYL)PYRAZOLE AS DOPAMINE AGONISTS [J].

BACH, NJ ;

KORNFELD, EC ;

JONES, ND ;

CHANEY, MO ;

DORMAN, DE ;

PASCHAL, JW ;

CLEMENS, JA ;

SMALSTIG, EB .

JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (05) :481-491

[8]

BARRETT RJ, 1982, EUR J PHARMACOL, V77, P79, DOI 10.1016/0014-2999(82)90541-6

[9]

BARRETT RJ, 1982, P W PHARMACOL SOC, V25, P39

[10]

BARRETT RJ, 1982, FED PROC, V41, P1587

← 1 2 3 4 5 6 7 8 →